Evidence map›Paper›PMID 19554653›Full record

ArticleWorld journal of gastroenterology2009

Clinicopathological analysis of paraganglioma with literature review.

Ning Feng, Wen-Yan Zhang, Xiao-Ting Wu

Abstract read
In one paragraph

Article in World journal of gastroenterology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Non-functional retroperitoneal paraganglioma: A case report.Journal of family medicine and primary care · 2019
    Article
  15. Article
  16. Review
  17. Locally Aggressive Primary Intraosseous Paraganglioma of Sacrum.Journal of clinical and diagnostic research : JCDR · 2017
    Article
  18. Article
  19. Article
  20. Extra- adrenal silent retroperitoneal paraganglioma: report of a rare case.Journal of clinical and diagnostic research : JCDR · 2014
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Ning FengDepartment of Gastrointestinal Surgery, West China Hospital, Sichuan University, Chengdu, Sichuan Province, China.
Wen-Yan Zhang
Xiao-Ting Wu

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimTo investigate the 152 cases of paragangliomas resected over the past 32 years in West China Hospital clinicopathologically.

methodsAll cases of paragangliomas diagnosed at the Department of Gastrointestinal Surgery and Department of Pathology, West China Hospital, China were reviewed. The pathological documents were supplied by the Department of Pathology, West China Hospital, and other necessary data were extracted from the hospital records. The statistical analyses were performed by survival analysis (Kaplan-Meier method), descriptive statistical analyses and chi(2) analysis.

resultsThe neuroendocrine marker vimentin was found to be selectively expressed in the benign tumors, and there were significant differences in the expression of those markers in both benign and malignant tumors. The survival analysis revealed that survival correlated significantly with the malignancy, metastasis and nodal status.

conclusionVimentin may be useful in the differential diagnosis between malignant and benign tumors. The difference in the expression of this marker in the tumors could be a clue to the future clinical diagnosis. The malignancy, metastasis and the nodal status may predict the prognosis of this disease.

Indexed as

AdolescentAdultAgedAged, 80 and overBiomarkers, TumorChildChinaFemaleHumansMaleMiddle AgedParagangliomaPrognosisSurvival AnalysisVimentinYoung AdultBiomarkers, TumorVimentin

Identifiers

PMID19554653
PMCPMC2702108

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.